Exicure, Inc. 2025 Financial Results Analysis
XCUR|EPS -$0.79|Rev $0|Net Loss $4.9M Company Overview Exicure, Inc. is a biotechnology company that acquired GPCR USA in January 2025 ...
Sunday, August 9, 2026
Tag: Exicure
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.